Chronic mTOR activation promotes cell survival in Merkel cell carcinoma

Area of Science:

• Oncology
• Cell Biology
• Dermatology

Background:

• Merkel cell carcinoma (MCC) is an aggressive skin cancer with increasing incidence.
• The roles of mTOR signaling and autophagy in MCC pathogenesis are not well understood.

Purpose of the Study:

• To investigate the status of mTOR activation and autophagy in MCC.
• To explore the effects of mTOR inhibition on autophagy and cell death in MCC cell lines.

Main Methods:

• Analysis of mTOR activation and autophagy in MCC tissues and cell lines.
• Treatment of primary human MCC cell lines with an mTOR inhibitor.
• Assessment of autophagy induction and cell death mechanisms (caspase-independent) following mTOR inhibition.
• Evaluation of the impact of autophagy inhibition on cell death.

Main Results:

• mTOR activation and suppressed autophagy are frequently observed in MCC.
• mTOR inhibition in MCC cell lines successfully induced autophagy.
• Cell death occurred independently of caspase activation but was dependent on autophagy.
• Autophagy inhibition partially rescued cells from mTOR inhibitor-induced death.

Conclusions:

• mTOR signaling plays a critical role in MCC cell survival.
• mTOR inhibition can induce caspase-independent autophagic cell death in MCC.
• Targeting the mTOR/autophagy pathway represents a potential therapeutic strategy for MCC.